Literature DB >> 30465320

Dynamics of hepatitis B virus serum markers in an acute hepatitis B patient in the incubation phase.

Shota Okamoto1, Kazumi Yamasaki2, Atsumasa Komori1, Seigo Abiru1, Shinya Nagaoka1, Akira Saeki1, Satoru Hashimoto1, Shigemune Bekki1, Hiroaki Okamoto3, Hiroshi Yatsuhashi1.   

Abstract

Patients with acute hepatitis B (AHB) usually present after developing symptoms; therefore, the temporal kinetics of viral markers during the incubation period have not been documented clearly. We describe an AHB infection before the onset of hepatitis, throughout the course of the disease and without anti-viral therapy. The patient initially visited our hospital for immunization against HBV and was found to be positive for viral markers: 0.0 IU/mL of anti-HBs, 0.06 S/CO of anti-HBc and 2.93 IU/mL of HBsAg. During the 14 days after his first visit, HBsAg, HBV DNA, HBe antigen and HBV core-related antigen, but not anti-HBc or anti-HBs, levels increased. On day 22, he developed acute hepatitis. The period of logarithmic viral replication was estimated to be 7.0 days. HBV genomic sequencing and phylogenetic analysis indicated transmission from the patient's wife. Although sexual intercourse could not be ruled, another possible route of transmission was the unusual occurrence of kissing his wife when she had macroscopic bleeding after tooth brushing, 2 months before his positive HBsAg result; the day of the episode being consistent with the calculated HBV replication velocity. This study reveals the temporal kinetics of viral markers during the incubation period of AHB.

Entities:  

Keywords:  Acute hepatitis; HBV; HBsAg; Incubation phase

Mesh:

Substances:

Year:  2018        PMID: 30465320     DOI: 10.1007/s12328-018-0925-6

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  12 in total

1.  MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets.

Authors:  Sudhir Kumar; Glen Stecher; Koichiro Tamura
Journal:  Mol Biol Evol       Date:  2016-03-22       Impact factor: 16.240

2.  Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  JAMA       Date:  1967-05-01       Impact factor: 56.272

3.  Identification of four novel subgenotypes (C13-C16) and two inter-genotypic recombinants (C12/G and C13/B3) of hepatitis B virus in Papua province, Indonesia.

Authors:  Pingki Pancawardani; Sulaiman Ngongu Depamede; Arif Wahyono; Suljid Jirintai; Shigeo Nagashima; Masaharu Takahashi; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  Virus Res       Date:  2011-09-08       Impact factor: 3.303

4.  Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.

Authors:  G J Webster; S Reignat; M K Maini; S A Whalley; G S Ogg; A King; D Brown; P L Amlot; R Williams; D Vergani; G M Dusheiko; A Bertoletti
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

5.  Tears from children with chronic hepatitis B virus (HBV) infection are infectious vehicles of HBV transmission: experimental transmission of HBV by tears, using mice with chimeric human livers.

Authors:  Haruki Komatsu; Ayano Inui; Tsuyoshi Sogo; Akihiko Tateno; Reiko Shimokawa; Tomoo Fujisawa
Journal:  J Infect Dis       Date:  2012-04-16       Impact factor: 5.226

6.  Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product.

Authors:  S Usuda; H Okamoto; H Iwanari; K Baba; F Tsuda; Y Miyakawa; M Mayumi
Journal:  J Virol Methods       Date:  1999-06       Impact factor: 2.014

7.  Experimental transmission of hepatitis B virus by semen and saliva.

Authors:  R M Scott; R Snitbhan; W H Bancroft; H J Alter; M Tingpalapong
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

8.  Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C.

Authors:  Yutaka Komiya; Keiko Katayama; Hisao Yugi; Masaaki Mizui; Harumichi Matsukura; Tetsushi Tomoguri; Yuzo Miyakawa; Ayako Tabuchi; Junko Tanaka; Hiroshi Yoshizawa
Journal:  Transfusion       Date:  2007-11-19       Impact factor: 3.157

9.  Hepatitis B: the virus and disease.

Authors:  T Jake Liang
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

10.  Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults.

Authors:  Kiyoaki Ito; Hiroshi Yotsuyanagi; Hiroshi Yatsuhashi; Yoshiyasu Karino; Yasuhiro Takikawa; Takafumi Saito; Yasuji Arase; Fumio Imazeki; Masayuki Kurosaki; Takeji Umemura; Takafumi Ichida; Hidenori Toyoda; Masashi Yoneda; Eiji Mita; Kazuhide Yamamoto; Kojiro Michitaka; Tatsuji Maeshiro; Junko Tanuma; Yasuhito Tanaka; Masaya Sugiyama; Kazumoto Murata; Naohiko Masaki; Masashi Mizokami
Journal:  Hepatology       Date:  2013-11-20       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.